KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

NovoCure (NVCR) Accumulated Depreciation & Amortization (2016 - 2025)

NovoCure's Accumulated Depreciation & Amortization history spans 12 years, with the latest figure at $41.9 million for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 29.59% to $41.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $41.9 million, a 29.59% increase, with the full-year FY2025 number at $41.9 million, up 29.59% from a year prior.
  • Accumulated Depreciation & Amortization hit $41.9 million in Q4 2025 for NovoCure, up from $32.3 million in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for NVCR hit a ceiling of $41.9 million in Q4 2025 and a floor of $22.1 million in Q4 2021.
  • Historically, Accumulated Depreciation & Amortization has averaged $29.6 million across 5 years, with a median of $28.0 million in 2023.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: increased 6.82% in 2022 and later grew 29.59% in 2025.
  • Tracing NVCR's Accumulated Depreciation & Amortization over 5 years: stood at $22.1 million in 2021, then increased by 6.82% to $23.6 million in 2022, then increased by 18.47% to $28.0 million in 2023, then increased by 15.56% to $32.3 million in 2024, then increased by 29.59% to $41.9 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for NVCR at $41.9 million in Q4 2025, $32.3 million in Q4 2024, and $28.0 million in Q4 2023.